News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
05-Jun-2012 - Birgitte Volck has been appointed Senior Vice President, Chief Medical Officer at Sobi with responsibility for Clinical Development, Regulatory Affairs, Drug Safety and Medical Affairs.Birgitte Volck is currently Executive Development Director, Bone, Neuroscience & Inflammation at Amgen Limited ...
03-Apr-2012 - Sobi has amended its share purchase agreement regarding the acquisition in 2005 of the pharmaceutical company Arexis AB, which included a number of development programs.According to the amended agreement, Sobi will not have any remaining development obligations towards the sellers. In addition, ...
02-Feb-2012 - Wills Hughes-Wilson has been appointed Vice President, Government Affairs & Policy with responsibility for Sobi's contacts with all stakeholders in the health policy area.Wills comes from Genzyme Corporation, now part of the French Sanofi Group, where she was Vice President Health/Market Access ...
06-Oct-2011 - Peter Edman, Head of R&D, will leave Sobi as of December 31, 2011."The years in Sobi have been exciting and rewarding", says Peter Edman. "During this time we have restructured and focused the research operations on recombinant protein projects within rare diseases, and taken the decision to ...
17-Aug-2011 - Biotech company Pharming Group NV announced that they have agreed an extension of their existing agreement with Swedish Orphan Biovitrum to include new territories in the Balkans, North Africa and the Middle East for the commercialization of Ruconest® (recombinant human C1 inhibitor) for the ...
27-Jun-2011 - Geoffrey McDonough has been appointed President and CEO of Swedish Orphan Biovitrum AB (Sobi) as of August 15, 2011. He will succeed Kennet Rooth, who has been acting CEO since January 1, 2011.Geoffrey McDonough is currently President of Europe, Middle East, and Africa (EMEA) of Genzyme ...
10-May-2011 - Biogen Idec and Swedish Orphan Biovitrum announced that the European Medicines Agency's (EMA) Pediatric Committee (PDCO) has adopted an opinion agreeing to the pediatric investigational plan for the companies' long-lasting, fully-recombinant Factor IX Fc fusion protein (rFIXFc).In accordance with ...
01-Mar-2011 - Swedish Orphan Biovitrum announced changes to its management team and a strengthening of its Business Development function.New appointments are: Lars Sandstöm CFO, Stefan Fraenkel, Head of Business Development and Åsa Stenqvist Vice President for IR and Communication, A new function is created; ...
31-Jan-2011 - Swedish Orphan Biovitrum announced a Removab® distribution agreement with Fresenius Biotech. Under the agreement Swedish Orphan Biovitrum (Sobi) will distribute Removab® exclusively in 15 European countries over 7 years. Removab® was granted marketing authorization by the European Commission in ...
30-Dec-2010 - Swedish Orphan Biovitrum announced that it has returned full development rights to Symphogen, co-developer of Sym001, for ITP (Immune Thrombocytopenic Purpura) treatment and for HDN (Hemolytic Disease in Newborn) prophylaxis, for strategic reasons. Sym001 is currently in clinical phase II for ...
© 1997-2024 LUMITOS AG, All rights reserved